Oric Pharmaceuticals (ORIC) Other financing activities (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Other financing activities came in at $1.3 million in Q1 2026, up 394.86% YoY from $253000.0 in Q1 2025, and up 32.63% on a QoQ basis from $944000.0 in Q4 2025.
Oric Pharmaceuticals (ORIC) Other financing activities (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Other financing activities data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Other financing activities rose 394.86% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 334.11% YoY) and the FY2025 annual result came in at $2.0 million, up 213.63% from the prior year.
- Other financing activities rose to $1.3 million in Q1 2026, from $944000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.3 million in Q1 2026 to a low of $1000.0 in Q3 2022.
- A 5-year average of $266666.7 and a median of $61000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities plunged 99.88% — and 2025, when it soared 6642.86%.
- Tracing ORIC's Other financing activities over 5 years: stood at $1000.0 in 2022, then soared by 2700.0% to $28000.0 in 2023, then slumped by 50.0% to $14000.0 in 2024, then soared by 6642.86% to $944000.0 in 2025, then jumped by 32.63% to $1.3 million in 2026.
- The last three Other financing activities figures came in at $1.3 million (Q1 2026), $944000.0 (Q4 2025), and $748000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 149,000.00 |
| Jun 30, 2026 | 149,000.00 |
| Mar 31, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 944,000.00 |
| Dec 31, 2025 | 944,000.00 |
| Sep 30, 2025 | 748,000.00 |
| Sep 30, 2025 | 748,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 253,000.00 |
| Mar 31, 2025 | 253,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 293,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Mar 31, 2024 | 198,000.00 |